GoPeptideGuide.com

This site is intended for research purposes only. Peptides are not recommended for human consumption.

Selank (10mg)

Table of Contents

Selank (10mg)

Quickstart Highlights

Selank 10mg dosage protocol is often utilized for its potential anxiolytic and nootropic properties, supporting enhanced mood, cognition, and stress management.

Dosing & Reconstitution Guide

Educational guide for reconstitution and dosing protocol

Selank (10mg Vial) Daily Approach (3 mL ≈ 3.33 mg/mL)

Week Daily Dosage (mcg) Units (per injection)
Weeks 1–2 200 mcg ~6 units
Weeks 3–4 300 mcg ~9 units
Weeks 5–6 400 mcg ~12 units
Weeks 7–8 500 mcg ~15 units

Typical gradual increase for nootropic/anxiolytic goals. Reconstitute with 3 mL to yield ~3.33 mg/mL (3,333 mcg/mL).
Note: At 200–300 mcg, the injected volume may be below ~10 units (6 or 9 units). Using a smaller-capacity insulin syringe (e.g., 50-unit or 30-unit) can improve measurement accuracy.

Note: This guide is for educational purposes only. Always consult with a qualified professional.

Protocol Overview

A concise summary of this once-daily regimen.

Dosing Protocol

Suggested daily injection approach to support anxiolytic and nootropic effects.

Storage Instructions

Proper storage ensures peptide integrity.

Suppilies Needed

Ensure you have these on hand for an 8-week cycle.

Important Notes

Practical tips to enhance safety and efficacy.

How This Works

Selank is a synthetic peptide derived from tuftsin, studied for its potential anxiolytic and cognitive benefits.

Potential Benefits & Side Effects

Users often report improved mood and reduced anxiety, though individual responses vary.

Lifestyle Factors

Complementary strategies can help maximize Selank’s potential benefits.

Injection Technique

Simple guidelines for safe daily injections.

Recommended Source

 We recommend Go Alpha Labs  for high-purity BPC-157 + TB-500 blend.

Why Go Alpha Labs?​

Important Note:

This guide is for educational purposes only. Always consult a qualified healthcare provider before starting or modifying any therapy.

References:

 

Source Link
Google Patents – WO2011082196A2 peptide patent View Source
PubMed Central (PMC5322660) – Clinical study on Selank View Source
Sciendo – Academic article on peptide use View Source
Wiley Online Library – 2017 Selank clinical study View Source
PubMed Central (PMC4757669) – Research on dosing protocols View Source
MedlinePlus.gov – Official medical instructions View Source
Frontiers in Pharmacology (2016) – Peptide mechanism insights View Source
Frontiers in Pharmacology (2017) – Follow-up peptide study View Source
PubMed Central (PMC5328971) – Further data on Selank usage View Source
Scroll to Top